GERN Q1 2021 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$137,000+163.5% YoY

Gross Profit

-$21M-15310.9% margin

Operating Income

-$28M-20769.3% margin

Net Income

-$28M-20309.5% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+174.0%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$33M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$259M

Total Liabilities

$57M

Stockholders' Equity

$201M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$137,000	$52,000	+163.5%
Gross Profit	-$21M	-$7M	-218.8%
Operating Income	-$28M	-$17M	-68.7%
Net Income	-$28M	-$16M	-70.1%